Multiple Myeloma: Hematology Journal Club 3.0
![](https://hematologylive.online/wp-content/uploads/2023/05/CME-Stamp-3.png)
![](https://hematologylive.online/wp-content/uploads/2022/04/Hematology-Journal-Club-Series-03_without-Panel-1.png)
This journal club was a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
Speaker: Dr. Amar Lal
Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates
This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
Speaker: Ramesh Pandita
Affiliations: Consultant Hematologist/ Oncologist , KCCC , Kuwait
This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
Speaker: Husni Hateeti
Affiliations: Consultant Hematologist, SKMC - Abu Dhabi, United Arab Emirates
This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
A panel discussion that included Dr. Amar Lal, Dr. Ramesh Pandita, and Dr. Husni Hateeti.